John Townsend
Fortune : - $ au 30/06/2026
Fortune : - $ au 30/06/2026
John W.
Townsend is Chief Financial Officer at Unicycive Therapeutics, Inc. since 2021.
Formerly, Mr. Townsend was Chief Accounting Officer at Plus Therapeutics, Inc. in 2015.
From 2017 to 2020, Mr. Townsend was Chief Accounting Officer & Controller at Guardion Health Sciences, Inc. Mr. Townsend completed an undergraduate degree at San Diego State University in 1993.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Directeur Financier/CFO | 01/03/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| GUARDION HEALTH SCIENCES, INC. | Comptroller/Controller/Auditor | 02/09/2020 |
| PLUS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30/06/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc. Pharmaceuticals: OtherHealth Technology Develops and distributes food & dietary supplements | Health Technology |
Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national